BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23559848)

  • 1. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.
    Dong Z; Noda K; Kanda A; Fukuhara J; Ando R; Murata M; Saito W; Hagiwara M; Ishida S
    Mol Vis; 2013; 19():536-43. PubMed ID: 23559848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization.
    Yoshikawa N; Noda K; Ozawa Y; Tsubota K; Mashima Y; Ishida S
    Mol Vis; 2012; 18():593-600. PubMed ID: 22419852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental choroidal neovascularization by curcumin in mice.
    Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q
    PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
    Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
    PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.
    Izumi-Nagai K; Nagai N; Ohgami K; Satofuka S; Ozawa Y; Tsubota K; Ohno S; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1679-85. PubMed ID: 18385091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
    Lai K; Xu L; Jin C; Wu K; Tian Z; Huang C; Zhong X; Ye H
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5702-12. PubMed ID: 21666238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD.
    Gammons MV; Fedorov O; Ivison D; Du C; Clark T; Hopkins C; Hagiwara M; Dick AD; Cox R; Harper SJ; Hancox JC; Knapp S; Bates DO
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6052-62. PubMed ID: 23887803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.
    Wu M; Liu Y; Zhang H; Lian M; Chen J; Jiang H; Xu Y; Shan G; Wu S
    Exp Eye Res; 2019 May; 182():93-100. PubMed ID: 30917905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide attenuates laser-induced choroidal neovascularization via M2 macrophage in a mouse model.
    Lai K; Gong Y; Zhao W; Li L; Huang C; Xu F; Zhong X; Jin C
    Biomed Pharmacother; 2020 Sep; 129():110312. PubMed ID: 32559620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
    Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
    J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor.
    Fukuhara J; Noda K; Murata M; Namba S; Kinoshita S; Dong Z; Ando R; Lennikov A; Kanda A; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):274-9. PubMed ID: 23233257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization.
    Song J; Lee K; Park SW; Chung H; Jung D; Na YR; Quan H; Cho CS; Che JH; Kim JH; Park JH; Seok SH
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3747-3754. PubMed ID: 30046816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
    Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein attenuates choroidal neovascularization.
    Kinoshita S; Noda K; Tagawa Y; Inafuku S; Dong Y; Fukuhara J; Dong Z; Ando R; Kanda A; Ishida S
    J Nutr Biochem; 2014 Nov; 25(11):1177-1182. PubMed ID: 25113565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.
    Gammons MV; Dick AD; Harper SJ; Bates DO
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5797-806. PubMed ID: 23761094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.
    Hatcher JM; Wu G; Zeng C; Zhu J; Meng F; Patel S; Wang W; Ficarro SB; Leggett AL; Powell CE; Marto JA; Zhang K; Ki Ngo JC; Fu XD; Zhang T; Gray NS
    Cell Chem Biol; 2018 Apr; 25(4):460-470.e6. PubMed ID: 29478907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.